comparison between single-dose esomeprazole- and pantoprazole-based triple therapy on the effectiveness for helicobacter pylori eradication in taiwanese population
Clicks: 276
ID: 174909
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
63.2
/100
276 views
225 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #26 of 188 articles by views in colloids and surfaces a: physicochemical and engineering aspects
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 188 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background and Study Aims. To compare the effectiveness of two regimens, single-dose esomeprazole- and pantoprazole-based triple therapy, for Helicobacter pylori (H. pylori) eradication.
Patients and Methods. A total of 453 patients were enrolled for H. pylori eradication. They were randomly assigned to either EAC group (Esomeprazole 40 mg once daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days) or PAC group (Pantoprazole 40 mg twice daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days). Follow-up endoscopy or urea breath test was scheduled 12–16 weeks after the eradication to evaluate the therapeutic response. Results. Higher eradication rate in EAC group than PAC group was shown by intention-to-treat analysis (EAC 72% versus PAC 55%, P<0.05) and per-protocol analysis (EAC 91% versus PAC 72%, P<0.05). The incidence of adverse effects (EAC 19% versus PAC 17%, P=0.712) and the compliance (EAC 87% versus PAC 91%, P=0.083) were comparable between these 2 groups.
Conclusions.
Single-dose esomeprazole-based triple therapy is effective for H. pylori eradication.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (111 words).
Try re-searching for a better abstract.
| Reference Key |
shih2012gastroenterologycomparison
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Hsiang-Yao Shih;Sophie S. W. Wang;Chao-Hung Kuo;Fu-Chen Kuo;Yi-Yu Chen;Meng-Chieh Wu;Bi-Chuang Weng;Yi-Chern Lee;Chi-Tan Hu;Deng-Chyang Wu;Yen-Hsu Chen |
| Journal | colloids and surfaces a: physicochemical and engineering aspects |
| Year | 2012 |
| DOI |
10.1155/2012/674324
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.